Cryptogenic organizing pneumonia risk factors: Difference between revisions
Created page with " __NOTOC__ {{Cryptogenic organizing pneumonitis}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ..." |
No edit summary |
||
| (11 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Cryptogenic organizing pneumonia}} | |||
{{CMG }} {{AE}} {{MKK}} | |||
==Overview== | |||
Common risk factors in the development of [[cryptogenic organizing pneumonia]] include infectious [[pneumonia]], [[Connective tissue disease|connective tissue diseases]], [[Immunological|immunologic]] diseases and [[inflammatory bowel disease]], [[organ transplantation]], [[medication]] use, breast [[radiation therapy]] and exposure to the [[toxin]]. | |||
==Risk Factors== | |||
{{ | Common risk factors in the development of [[cryptogenic organizing pneumonia]] include:<ref name="pmid11790668">{{cite journal |vauthors= |title=American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 |journal=Am. J. Respir. Crit. Care Med. |volume=165 |issue=2 |pages=277–304 |date=January 2002 |pmid=11790668 |doi=10.1164/ajrccm.165.2.ats01 |url=}}</ref><ref name="urlOrganising pneumonia | Thorax">{{cite web |url=http://thorax.bmj.com/content/55/4/318 |title=Organising pneumonia | Thorax |format= |work= |accessdate=}}</ref> | ||
*Infectious [[pneumonia]] | |||
*[[Connective tissue disease|Connective tissue diseases]] | |||
*[[Immunological|Immunologic]] diseases and [[inflammatory bowel disease]] | |||
*[[Organ transplantation]] | |||
*[[Medication]] use | |||
*Breast [[radiation therapy]] | |||
*Exposure to the [[toxin]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
{{WH}} | |||
{{WS}} | |||
Latest revision as of 03:22, 7 March 2018
|
Cryptogenic Organizing Pneumonia Microchapters |
|
Differentiating Cryptogenic organizing pneumonia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cryptogenic organizing pneumonia risk factors On the Web |
|
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia risk factors |
|
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
|
Risk calculators and risk factors for Cryptogenic organizing pneumonia risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Common risk factors in the development of cryptogenic organizing pneumonia include infectious pneumonia, connective tissue diseases, immunologic diseases and inflammatory bowel disease, organ transplantation, medication use, breast radiation therapy and exposure to the toxin.
Risk Factors
Common risk factors in the development of cryptogenic organizing pneumonia include:[1][2]
- Infectious pneumonia
- Connective tissue diseases
- Immunologic diseases and inflammatory bowel disease
- Organ transplantation
- Medication use
- Breast radiation therapy
- Exposure to the toxin
References
- ↑ "American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001". Am. J. Respir. Crit. Care Med. 165 (2): 277–304. January 2002. doi:10.1164/ajrccm.165.2.ats01. PMID 11790668.
- ↑ "Organising pneumonia | Thorax".